BlackRock’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-250,100
Closed -$89.8M 5500
2021
Q1
$89.8M Buy
+250,100
New +$80.4M ﹤0.01% 2251
2020
Q4
Sell
-192,400
Closed -$51.7M 5076
2020
Q3
$51.7M Sell
192,400
-189,900
-50% -$51.1M ﹤0.01% 2279
2020
Q2
$101M Buy
+382,300
New +$102M ﹤0.01% 1842

Other funds holding ELV

BlackRock's ELV Position: Q2 2026 in Review

BlackRock reduced its Elevance Health (ELV) stake by 4.5% in Q2 2026, selling an estimated $332M and leaving 18,991,090 shares worth $7.34B. The position accounts for 0.11% of the portfolio, ranked #141.

BlackRock first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $11.2B in Q2 2024. 1,608 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • BlackRock held 18,991,090 shares of Elevance Health worth $7.34B as of Q2 2026.
  • BlackRock sold 896,021 Elevance Health shares in Q2 2026, an estimated $332M.
  • Elevance Health made up 0.11% of BlackRock's portfolio in Q2 2026, its #141 holding.
  • BlackRock first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
  • BlackRock's Elevance Health position peaked at $11.2B in Q2 2024.
  • 1,608 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.